Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 13

1.

Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.

Hashimoto K, Ishiwata K.

Curr Pharm Des. 2006;12(30):3857-76. Review.

PMID:
17073684
2.

Preclinical acute toxicity studies and dosimetry estimates of the novel sigma-1 receptor radiotracer, [18F]SFE.

Waterhouse RN, Zhao J, Stabin MG, Ng H, Schindler-Horvat J, Chang RC, Mirsalis JC.

Mol Imaging Biol. 2006 Sep-Oct;8(5):284-91.

PMID:
16924428
4.

Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.

Lever JR, Gustafson JL, Xu R, Allmon RL, Lever SZ.

Synapse. 2006 May;59(6):350-8.

PMID:
16463398
5.

N-[18F]4'-fluorobenzylpiperidin-4yl-(2-fluorophenyl) acetamide ([18F]FBFPA): a potential fluorine-18 labeled PET radiotracer for imaging sigma-1 receptors in the CNS.

Mach RH, Gage HD, Buchheimer N, Huang Y, Kuhner R, Wu L, Morton TE, Ehrenkaufer RL.

Synapse. 2005 Dec 15;58(4):267-74.

PMID:
16206186
6.

Behavioral pharmacology of sigma-ligands.

Skuza G, Wedzony K.

Pharmacopsychiatry. 2004 Nov;37 Suppl 3:S183-8. Review.

PMID:
15547784
7.

Potential antidepressant activity of sigma ligands.

Skuza G.

Pol J Pharmacol. 2003 Nov-Dec;55(6):923-34. Review.

8.
9.

Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia.

Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Arinami T.

Neurosci Lett. 1998 Nov 20;257(1):45-8.

PMID:
9857962
10.
11.
12.

Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H.

Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8072-7.

13.

Supplemental Content

Support Center